The National Sleep Foundation released the following statement regarding the announcement from the U.S. Food and Drug Administration, ?FDA Requests Label Change for All Sleep Disorder Drug Products:?
A generic drug already used by millions of Americans for high blood pressure and prostate problems has been found to improve sleep and lessen trauma nightmares in veterans with posttraumatic stress disorder (PTSD).
Heart failure patients with untreated sleep apnea are more likely to die than those without this sleep disorder, says a study to be published in the Journal of the American College of Cardiology.
People with restless legs syndrome (RLS), especially the elderly, may be at an increased risk of developing cardiovascular disease, according to a study published in the April 10, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
Barr Pharmaceuticals, Inc. confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a patent challenge for Sanofi-Aventis U.S. LLC’s Ambien CR(R) (Zolpidem Tartrate Extended-Release Tablets), 6.25mg & 12.5mg.
Cephalon, Inc. (Nasdaq: CEPH) announced that it has received an approvable letter, together with draft labeling, from the U.S. Food and Drug Administration (FDA) for its new drug application (NDA) for NUVIGIL(TM) (armodafinil) Tablets [C-IV] for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome (OSAHS) and shift work sleep disorder (SWSD).
Sleep continuity disturbance impairs endogenous pain-inhibitory function and increases spontaneous pain in women.
A mild head injury can increase your chance of developing a sleep disorder, according to a study published in the April 3, 2007, issue of Neurology?, the scientific journal of the American Academy of Neurology.
Patients taking medications to treat bipolar disorder are more likely to get well faster and stay well if they receive intensive psychotherapy, according to results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), funded by the National Institutes of Health?s (NIH) National Institute of Mental Health (NIMH).
For overweight and obese individuals, the incidence of asthma increases by 50 percent, as compared to those of normal weight, according to a meta-analysis of seven studies on severe asthma involving 333,102 patients.